CVM CEL-SCI Corporation About to break out.
If you can get in under .47 this should break out to a least .51 if it breaks .51 this will move fast.
News and HEAD AND SHOULDERS BOTTOM
Cel-Sci Reports European Patent On Cancer Drug
08:17 AM EDT, 07/11/2016 (MT Newswires) -- Cel-Sci(CVM) Monday reported that it has been granted a new European Union patent covering its investigational phase 3 cancer drug leucocyte interleukin.
The drug "pre-sensitizes" cancer cells prior to radiation or chemotherapy, making the cells more vulnerable to treatment.
Cel-sci said the patent is titled, "A Method Of Pre-Sensitizing Cancer Prior To Treatment With Radiation and/or Chemotherapy And A Novel Cytokine Mixture," and is not limited to any one particular type of cancer.
Cel-Sci (CVM) noted that its ongoing phase 3 clinical trial in head and neck cancer patients is administering leucocyte interleukin therapy as part of a first-line treatment, before any other treatments and prior to surgery, followed by radiation or concurrent chemo-radiotherapy.
Price: 0.47, Change: , Percent Change:
